MTOR and breast cancer: Accordingly, Corominas-Faja et al. 42 used modified stem cell technology of Yamanaka et al. 42 in an attempt to construct stable CSC lines, and they observed the transcriptional suppression of mTOR repressors to be a fundamental procedure occurring in luminal-like breast cancer cells throughout the acquisition of CSC-like properties.